InvestorsHub Logo
Followers 120
Posts 19685
Boards Moderated 0
Alias Born 08/27/2005

Re: The ELTP King post# 289757

Tuesday, 05/22/2018 2:59:16 AM

Tuesday, May 22, 2018 2:59:16 AM

Post# of 410859

Something big coming?




Ama, anything in the cue slated for approval will be big. But as NH said last summer the SunGen products could be more lucrative then the ADF portfolio. That's saying something. Unlike the generics currently out there, Elite/SunGen will be using SunGen's PIP as part of their generic line which WILL set them apart from the generics currently out there.


That $1.6 billion dollar generic coming as an ANDA will be using this PIP. How much market share will Elite/SunGen get? Will have to see how the technology compares to what is currently out there, then see if it is preferred over what is currently out there.

Even a small 5% is $80 million. Plus revenues currently coming in is about $100 million per year. So $0.10 times a P/E of 14.

But I got ahead of myself, there will be other approvals by then so that drug revenue will just be additive and the P/E ratio of 14 which is very conservative.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News